ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,568Medicare Part D Prescriptions Filled, Including Refills

Rank: 47 out of 487

$435K Total Retail Price of All Prescriptions

Rank: 59 out of 487

393 Patients Receiving at Least One Drug in Part D
65%Patients 65 Years and Older
55% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Idaho
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 393 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

22% of this provider’s 393 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 5,038 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

21% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$51 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

22 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Idaho
OMEPRAZOLE 387 237 1 2
HYDROCODONE-ACETAMINOPHEN 370 135 S3 2 3
LISINOPRIL 301 202 3 5
LEVOTHYROXINE SODIUM 258 210 4 1
METFORMIN HCL 252 163 5 8
FUROSEMIDE 204 171 6 7
TRAMADOL HCL 196 63 7 19
SIMVASTATIN 192 129 8 4
LOVASTATIN 169 102 9 30
GABAPENTIN 145 83 10 13
HYDROCHLOROTHIAZIDE 137 107 11 9
POTASSIUM CHLORIDE 136 108 12 10
METOPROLOL TARTRATE 126 104 13 17
ZOLPIDEM TARTRATE 122 69 14 14
AMLODIPINE BESYLATE 113 95 15 6
CYMBALTA 111 35 16 34
WARFARIN SODIUM 97 76 17 11
METHADONE HCL 95 12 S2 18 65
SULFAMETHOXAZOLE-TRIMETHOPRIM 92 50 19 90
FLUOXETINE HCL 89 27 20 28
CYCLOBENZAPRINE HCL 84 30 R 21 64
MELOXICAM 83 50 22 26
PROAIR HFA 83 60 22 40
CARISOPRODOL 82 12 R 24 76
TRAZODONE HCL 82 58 24 22
SERTRALINE HCL 82 36 24 21
LEVEMIR FLEXPEN 77 58 27 212
LYRICA 74 33 28 77
METOPROLOL SUCCINATE 71 60 29 15
CARVEDILOL 69 58 30 32
PROMETHAZINE HCL 69 0 R 30 101
LISINOPRIL-HYDROCHLOROTHIAZIDE 69 0 30 24
IBUPROFEN 68 26 33 78
AZITHROMYCIN 68 54 33 50
RANITIDINE HCL 65 23 35 39
ENALAPRIL MALEATE 59 58 36 80
NEXIUM 58 30 37 41
PRAVASTATIN SODIUM 57 55 38 20
NAPROXEN 55 21 39 109
OXYCODONE HCL 54 0 S2 40 57
PROPRANOLOL HCL 54 41 40 92
ATENOLOL 54 41 40 23
METHYLPREDNISOLONE 53 38 43 157
CEPHALEXIN 52 24 44 108
CITALOPRAM HBR 51 46 45 12
GEMFIBROZIL 50 48 46 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 12, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.